Gadolinium MRI Contrast Dye Information Provided by Lawyer Central
Lawyer Central has recently updated its Gadolinium Contrast Dye Resource Center, which provides information to consumers about the risks associated with the use of gadolinium based MRI contrast dyes.
(EMAILWIRE.COM, February 05, 2009 ) New York, NY - Lawyer Central has recently updated its Gadolinium Contrast Dye Resource Center, which provides information to consumers about the risks associated with the use of gadolinium based MRI contrast dyes. Although gadolinium contrast dyes pose no serious risk for most individuals, those with kidney problems may be unable to quickly eliminate the gadolinium from their bodies following the contrast dye injection for an MRI. This prolonged exposure to gadolinium can lead to the development of a condition known as Nephrogenic Systemic Fibrosis (NSF).
Before the recent discovery of the potential side effects of gadolinium, doctors praised the element because it allowed for enhanced imaging in MRIs. Gadolinium produces a visible contrast in blood vessels, organs and tissues, which aids medical professionals in detecting tumors or abnormal tissues. In the United States, gadolinium was manufactured by GE Healthcare, Bayer HealthCare Pharmaceuticals, Tyco/Mallinckrodt and Bracco Diagnostics under the following brand names: Magnevist, MultiHance, Omniscan, OptiMARK and ProHance.
Although gadolinium has useful properties in the medical field, it also poses health risks for patients with kidney conditions. Recent studies have shown a link between gadolinium and NSF, the potentially life-threatening disease that causes fibrosis of the skin, eyes, joints and internal organs. The first diagnosis of Nephrogenic Systemic Fibrosis occurred in 1997. In serious cases, it can lead to immobility and breathing difficulties, with the potential to be fatal. This is a relatively new disease and no cure has been discovered yet. The Food and Drug Administration (FDA) issued three warnings about the effects of gadolinium between June 2006 and May 2007. In addition, several lawsuits have been filed aimed at the manufacturers of gadolinium contrast dye alleging that these manufacturers failed to warn consumers about its risks and failed to adequately test it.
To learn more about gadolinium and NSF, visit http://injury.lawyercentral.com/Gadolinium-Contrast-Dye-Lawyers-Attorneys--1-106.html. Lawyer Central’s gadolinium lawyers are offering a free case evaluation for individuals who have developed NSF as a result of gadolinium exposure. If you are interested in learning about the legal rights of individuals who have been harmed by gadolinium, fill out the form on the right side of the page. Gadolinium attorneys can advise you of your legal options and help you get the justice you deserve.
About Lawyer Central
The Lawyer Central Network is an exclusive nationwide network of attorneys highly dedicated to their unique areas of practice, including gadolinium contrast dye litigation. Lawyer Central is emerging as the leading public relations and mixed media marketing organization for fast-growing law firms and forward-thinking attorneys. Lawyer Central membership includes a variety of media exposure ranging from practice area video filming, through interviews and complete public relations and internet relations management.
Before the recent discovery of the potential side effects of gadolinium, doctors praised the element because it allowed for enhanced imaging in MRIs. Gadolinium produces a visible contrast in blood vessels, organs and tissues, which aids medical professionals in detecting tumors or abnormal tissues. In the United States, gadolinium was manufactured by GE Healthcare, Bayer HealthCare Pharmaceuticals, Tyco/Mallinckrodt and Bracco Diagnostics under the following brand names: Magnevist, MultiHance, Omniscan, OptiMARK and ProHance.
Although gadolinium has useful properties in the medical field, it also poses health risks for patients with kidney conditions. Recent studies have shown a link between gadolinium and NSF, the potentially life-threatening disease that causes fibrosis of the skin, eyes, joints and internal organs. The first diagnosis of Nephrogenic Systemic Fibrosis occurred in 1997. In serious cases, it can lead to immobility and breathing difficulties, with the potential to be fatal. This is a relatively new disease and no cure has been discovered yet. The Food and Drug Administration (FDA) issued three warnings about the effects of gadolinium between June 2006 and May 2007. In addition, several lawsuits have been filed aimed at the manufacturers of gadolinium contrast dye alleging that these manufacturers failed to warn consumers about its risks and failed to adequately test it.
To learn more about gadolinium and NSF, visit http://injury.lawyercentral.com/Gadolinium-Contrast-Dye-Lawyers-Attorneys--1-106.html. Lawyer Central’s gadolinium lawyers are offering a free case evaluation for individuals who have developed NSF as a result of gadolinium exposure. If you are interested in learning about the legal rights of individuals who have been harmed by gadolinium, fill out the form on the right side of the page. Gadolinium attorneys can advise you of your legal options and help you get the justice you deserve.
About Lawyer Central
The Lawyer Central Network is an exclusive nationwide network of attorneys highly dedicated to their unique areas of practice, including gadolinium contrast dye litigation. Lawyer Central is emerging as the leading public relations and mixed media marketing organization for fast-growing law firms and forward-thinking attorneys. Lawyer Central membership includes a variety of media exposure ranging from practice area video filming, through interviews and complete public relations and internet relations management.
Contact Information:
Lawyer Central
Liz Ryan
Tel: 908-222-8848
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Lawyer Central
Liz Ryan
Tel: 908-222-8848
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Press Release Keywords:
gadolinium attorneys, gadolinium mri, gadolinium contrast, gadolinium lawyer, gadolinium attorney, gadolinium lawsuit
gadolinium attorneys, gadolinium mri, gadolinium contrast, gadolinium lawyer, gadolinium attorney, gadolinium lawsuit
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |




